COVID-19: use of ACE inhibitors and angiotensin-receptor blockers
Posted 25 Mar 2020
David Millar-Jones examines recent newspaper stories on the use of ACE inhibitors and angiotensin-receptor blockers in people with COVID-19, and their implications for primary care
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page